Pharma Reviews: Why investors should be more worried about Lupin than DRL

Muted fourth-quarter performance saw stocks of the pharma majors Dr ... Its acquisition of Gavis — the largest buyout by an Indian pharma company ...
Read more: Why investors should be more worried about Lupin than DRL